Search Results 371-380 of 16258 for Chronic Lymphocytic Leukemia
Currently, CAR -T cell therapy is FDA approved for: Relapsed, refractory B-cell acute lymphoblastic leukemia. Relapsed, refractory B-cell non-Hodgkin's lymphoma ...
Ponatinib is used to treat chronic phase chronic myeloid leukemia (CML) ... acute lymphoblastic leukemia (Ph+ ALL). It is also used alone in patients ...
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region. Acta Haematol. 2024; 147 (3):260-279 Epub 2023 Sept 26
A brief increase in certain white blood cells, called lymphocytes, is ... Lymphocytosis and chronic lymphatic leukaemia: Investigation and management.
... acute lymphoblastic leukemia. "Each dose is an individualized treatment made by genetically changing the patient's own T-cells to strengthen those cells ...
Nearly everyone has been affected by cancer, either through a personal diagnosis or that of a loved one. ... chronic lymphocytic leukemia and, soon, acute myeloid ...
Chronic lymphocytic leukemia · Chronic myelogenous leukemia · Colon cancer · Cyclothymia (cyclothymic disorder) · Dementia · Depression (major depressive ...
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...
... Chronic Lymphocytic Leukemia (CLL) with controls from a normal household and age-matched population. A Study of Investigational Immunotherapy to Determine ...
Bone marrow hematopoietic dysfunction in patients with untreated chronic lymphocytic leukemia ... The role of phenol soluble modulins in chronic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.